InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Chan Gerald, Director. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 6 reports have been logged. History available since 1 January 2022. The latest transaction was disclosed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Chan Gerald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
25,666 sharesCommon StockSEC:0001193125-26-224606:0
7,961 shares0Common StockSEC:0001492422-26-000012:0
6,267 shares0Common StockSEC:0001127602-25-000400:0
3,341 shares0Common StockSEC:0001127602-24-000114:0
3,867 shares0Common StockSEC:0000899243-23-000670:0
4,230 shares0Common StockSEC:0001127602-22-000727:0
6 of 6 declarations
About Chan Gerald
Chan Gerald is a Board Member at Apellis Pharmaceuticals, Inc. He contributes to the strategy and governance of the company, ensuring that decisions made align with shareholder interests. His expertise in the pharmaceutical sector is an asset for Apellis, fostering innovation and growth.
